Indivior PLC (INDV)
NASDAQ: INDV · Real-Time Price · USD
32.54
-0.35 (-1.06%)
At close: Jan 16, 2026, 4:00 PM EST
32.58
+0.04 (0.12%)
After-hours: Jan 16, 2026, 7:58 PM EST
Indivior Market Cap
Indivior has a market cap or net worth of $4.06 billion as of January 16, 2026. Its market cap has increased by 161.54% in one year.
Market Cap
4.06B
Enterprise Value
3.97B
1-Year Change
161.54%
Ranking
Category
Stock Price
$32.54
Market Cap Chart
Since December 29, 2014, Indivior's market cap has increased from $1.53B to $4.06B, an increase of 165.44%. That is a compound annual growth rate of 9.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 4.06B | -9.31% |
| Dec 31, 2025 | 4.48B | 188.39% |
| Dec 31, 2024 | 1.55B | -25.50% |
| Dec 29, 2023 | 2.09B | -29.77% |
| Dec 29, 2022 | 2.97B | 22.55% |
| Dec 31, 2021 | 2.42B | 125.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |